Gene · 8614
Papers1,289
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,289
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 42809369 | PubTator, text mining | PubMed |
| A Hypoxia Associated STC2 High Endothelial Subpopulation is Linked to Lipid Metabolic Reprogramming, Pathological Angiogenesis, and Immune Remodeling in Head and Neck Squamous Cell Carcinoma. | Int J Gen Med | 2026 | 42801171 | PubTator, text mining | PubMed |
| Exploring the Impact of Urolithins A and B on Muscle Health: A Transcriptomic Analysis in Human Myotubes. | J Cachexia Sarcopenia Muscle | 2026 | 42773997 | PubTator, text mining | PubMed |
| GCH1, identified by a ferroptosis-related prognostic model, contributes to progression and drug resistance of esophageal cancer. | Chin J Cancer Res | 2026 | 42713103 | PubTator, text mining | PubMed |
| Integrative transcriptomic analysis identifies shared coding and non-coding biomarkers in tongue squamous cell carcinoma across diverse populations. | Discov Oncol | 2026 | 42658318 | PubTator, text mining | PubMed |
| A novel hypoxia-related signature for predicting prognosis, immune characteristics, and therapeutic response in hepatocellular carcinoma. | Discov Oncol | 2026 | 42584769 | PubTator, text mining | PubMed |
| A Three-Gene Prognostic Signature Driven by an ER Stress-Associated ceRNA Network: Integrating Single-Cell Transcriptomics and Cross-Platform Validation in Hepatocellular Carcinoma. | Curr Issues Mol Biol | 2026 | 42510982 | PubTator, text mining | PubMed |
| Size in small-for-gestational-age neonates correlates with insulin-like growth factor-binding protein proteolysis and insulin-like growth factor-I bioavailability. | J Endocr Soc | 2026 | 42491477 | PubTator, text mining | PubMed |
| Identification and Prognostic Analysis of Immune-Related Genes Co-Regulated by Key Histone Modifications in Breast Cancer. | Curr Issues Mol Biol | 2026 | 42353587 | PubTator, text mining | PubMed |
| MYC_V1-Related Genes Affect Gastric Cancer Proliferation by Regulating Energy Metabolism and Analysis of Therapeutic Targets. | Int J Mol Sci | 2026 | 42278393 | PubTator, text mining | PubMed |
| Integrated Analysis Identifies an Anoikis-Related Gene Signature for Predicting Prognosis in Patients With Triple-Negative Breast Cancer. | IET Syst Biol | 2026 | 42258564 | PubTator, text mining | PubMed |
| A Multiomics Study Exploring Biomarkers of Toxicity Induced by Silica Nanoparticles on BEAS-2B Cells. | J Proteome Res | 2026 | 42233238 | PubTator, text mining | PubMed |
| STC2 mediates hypoxia-induced immunosuppression and tumorigenesis in hepatocellular carcinoma. | Cell Signal | 2026 | 42217552 | PubTator, text mining | PubMed |
| Integrative Bulk and Single-Cell Transcriptomic Analysis Identifies a Hypoxia- and Lipid Metabolism-Related Prognostic Signature in Oral Squamous Cell Carcinoma: A Retrospective Study. | Int J Mol Sci | 2026 | 42196541 | PubTator, text mining | PubMed |
| Investigating the immune-modulatory association of miRNAs in HPV-associated HNSCC individuals: A bioinformatics approach. | Adv Protein Chem Struct Biol | 2026 | 42177072 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals glycolytic heterogeneity and identifies STC2 as a key regulator of metabolic reprogramming in osteosarcoma. | Mol Cell Biochem | 2026 | 42166004 | PubTator, text mining | PubMed |
| TMED2 regulates macrophage polarization through MEK/ERK signaling pathway for osteosarcoma progression promotion. | Mol Cell Biochem | 2026 | 42165997 | PubTator, text mining | PubMed |
| Adrenal-derived factors drive progression of sclerotic prostate cancer in bone. | Endocr Relat Cancer | 2026 | 42149634 | PubTator, text mining | PubMed |
| Transcriptomics and Mendelian randomization studies reveal the critical role of Stanniocalcin-2 in linking perfluorinated compound-exposure to colorectal cancer. | Front Public Health | 2026 | 42130894 | PubTator, text mining | PubMed |
| STC2-mediated calcium homeostasis dysregulation in the osteosarcoma microenvironment: Insights from single-cell sequencing and machine learning. | Transl Oncol | 2026 | 41985319 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8614/papers